153 related articles for article (PubMed ID: 12839936)
1. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.
Khare S; Mustafi R; Cerda S; Yuan W; Jagadeeswaran S; Dougherty U; Tretiakova M; Samarel A; Cohen G; Wang J; Moore C; Wali R; Holgren C; Joseph L; Fichera A; Li YC; Bissonnette M
Nutr Cancer; 2008; 60(3):389-400. PubMed ID: 18444174
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
4. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
5. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
6. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
Liu W; Reinmuth N; Stoeltzing O; Parikh AA; Tellez C; Williams S; Jung YD; Fan F; Takeda A; Akagi M; Bar-Eli M; Gallick GE; Ellis LM
Cancer Res; 2003 Jul; 63(13):3632-6. PubMed ID: 12839952
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
Hu Y; Le Leu RK; Young GP
Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.
Wali RK; Frawley BP; Hartmann S; Roy HK; Khare S; Scaglione-Sewell BA; Earnest DL; Sitrin MD; Brasitus TA; Bissonnette M
Cancer Res; 1995 Nov; 55(22):5257-64. PubMed ID: 7585585
[TBL] [Abstract][Full Text] [Related]
13. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
[TBL] [Abstract][Full Text] [Related]
14. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
Kwon Y; Magnuson BA
Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
[TBL] [Abstract][Full Text] [Related]
15. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
Shih CK; Chiang W; Kuo ML
Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385
[TBL] [Abstract][Full Text] [Related]
16. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
18. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
Liu CY; Lai YY; Lo CJ
J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
20. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
Fong LY; Zhang L; Jiang Y; Farber JL
J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]